drugset / Trial / NCT01779258

Emollients in the Management of Atopic Dermatitis

NCT01779258

Phase 3 Completed 347 enrolled Pierre Fabre Laboratories
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to confirm that emollients play a major role in the maintenance therapy after clearing of inflammatory lesions and can reduce occurrence of flares in children with atopic dermatitis.

Timeline

Start
2013-02
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Paraffin Unknown
Background Locapred@ Unknown
Background Locatop@ Unknown

Indications